Company / Net Income
Whitehawk Therapeutics, Inc. Net Income History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$63.7M
FY2025
5-year range
-$110.1M / -$3.5M
FY2021-FY2025
Trend
+3.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income has fluctuated over the past 8 years, ranging from -$110M in FY2022 to -$3M in FY2021.
Based on SEC 10-K filings.
-$64M in FY2025.
Declined from -$61M to -$64M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net income increased 3.2% year-over-year.
- Peak net income was recorded in FY2021.
- Lowest net income in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$63.7M | +3.2% |
| FY2024 | -$65.8M | -8.7% |
| FY2023 | -$60.5M | +45.0% |
| FY2022 | -$110.1M | -3065.3% |
| FY2021 | -$3.5M | +85.1% |
| FY2020 | -$23.3M | -123.8% |
| FY2019 | -$10.4M | +51.4% |
| FY2018 | -$21.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026